DnB Asset Management
GMED icon

DnB Asset Management’s Globus Medical GMED Stock Holding History

DnB Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.27M Sell
66,684
-8,172
-11% -$695K 0.01% 475
2026
Q1 		$6.45M Sell
74,856
-86,985
-54% -$7.81M 0.02% 385
2025
Q4 		$14.1M Sell
161,841
-39,077
-19% -$2.97M 0.05% 230
2025
Q3 		$11.5M Buy
200,918
+67,911
+51% +$3.91M 0.04% 269
2025
Q2 		$7.85M Buy
133,007
+18,032
+16% +$1.17M 0.03% 305
2025
Q1 		$8.42M Buy
+114,975
New +$9.5M 0.04% 286

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

DnB Asset Management's GMED Position: Q2 2026 in Review

DnB Asset Management reduced its Globus Medical (GMED) stake by 11% in Q2 2026, selling an estimated $695K and leaving 66,684 shares worth $5.27M. The position accounts for 0.01% of the portfolio, ranked #475.

DnB Asset Management first reported a position in GMED in Q1 2025 and has held it in 6 quarters since. The position peaked at $14.1M in Q4 2025. 380 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • DnB Asset Management held 66,684 shares of Globus Medical worth $5.27M as of Q2 2026.
  • DnB Asset Management sold 8,172 Globus Medical shares in Q2 2026, an estimated $695K.
  • Globus Medical made up 0.01% of DnB Asset Management's portfolio in Q2 2026, its #475 holding.
  • DnB Asset Management first reported a position in Globus Medical in Q1 2025 and has held it in 6 quarters since.
  • DnB Asset Management's Globus Medical position peaked at $14.1M in Q4 2025.
  • 380 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.